Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in African American women, caused by hair care, genetics, and environment, needs more research for better treatment.

Lotion with piroctone olamine and triclosan improves hair loss in men.

The vitamin D receptor is involved in multiple body functions beyond calcium regulation, including immune response and rapid reactions not related to gene activity.

Hair follicle development is controlled by interactions between skin tissues and specific molecular signals.

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

Fat tissue-derived cells show promise for repairing body tissues, but more research and regulation are needed for safe use.

Acne affects most teenagers and can continue into adulthood, with various treatments available that show improvement but have concerns like antibiotic resistance and side effects.

Stem cells help heal skin wounds by moving and changing roles, working with other cells, and needing more research on their activation and behavior.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

The 2003 guidelines suggest that while some treatments can regrow hair in alopecia areata, none alter the disease's progression, and wigs may be the best option for extensive hair loss.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

Inflammation may be linked to hair loss, and targeting specific enzymes could help treat it.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Rhodococcus equi causes severe pneumonia in young foals, and effective vaccines are needed due to foals' weak immune responses.

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

Psoriasis skin changes are complex and might need several biopsies for a clear diagnosis.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Olive oil compounds may help prevent cancer in animals, but human results are mixed.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Male pattern baldness involves smaller hair follicles, larger oil glands, and other tissue changes, but not major blood supply issues.

Prolactin affects hair growth cycles and can cause early hair follicle regression.

Using human fat tissue derived stem cells in micrografts can safely and effectively increase hair density in people with hair loss.